UK’s GSK to Buy US-Based Cancer Drugmaker Nuvalent for $10.6 Billion

by

June ⁠9 (Reuters) – ⁠British drugmaker ⁠GSK on ​Tuesday ‌agreed to ‌acquire ⁠U.S.-listed cancer ⁠drug developer Nuvalent ​for $10.6 billion to ​boost its ⁠lung cancer ⁠portfolio.

The ⁠all-cash deal ​values Nuvalent at ​approximately $124 ⁠per ⁠share, a 40% premium to ⁠its last closing price.

(Reporting by DhanushVignesh Babu and ⁠Yadarisa Shabong in Bengaluru; Editing ​by Mrigank ​Dhaniwala)

Copyright 2026 Thomson Reuters.

Photos You Should See – June 2026

TOPSHOT - Hindu devotees of the Tengger community are seen through low-lying clouds at sunrise as they ascend the active Mount Bromo volcano to present offerings of rice, fruit, livestock and other items as part of the Yadnya Kasada festival near Probolinggo, East Java province on June 1, 2026. The Yadnya Kasada ceremony is a ritual of the Tenggerese people, a sub-ethnic group of Javanese in eastern Java, in which offerings are thrown into the crater of Mount Bromo as a form of gratitude, prayer for safety, and fulfillment of a legendary vow to the mountain's deity. (Photo by JUNI KRISWANTO / AFP via Getty Images)

Leave a Comment